Persistent proteomic alterations in the medial prefrontal cortex with abstinence from cocaine self-administration. 2009

Melinda E Lull, and Mandi S Erwin, and Drake Morgan, and David C S Roberts, and Kent E Vrana, and Willard M Freeman
Department of Pharmacology, Penn State College of Medicine.

Neuroproteomic studies of drug abuse offer the potential for a systems-level understanding of addiction. Understanding cocaine-responsive alterations in brain protein expression that persist even with extended abstinence may provide insight into relapse liability. In the current study, protein changes in the medial prefrontal cortex of cocaine self-administering rats following 1 and 100 days of enforced abstinence were quantified by 2D-DIGE. We have previously reported increased drug-seeking and drug-taking, as well as mRNA and epigenetic changes in this model even after 100 days of enforced abstinence. A number of statistically-significant changes in proteins relating to synapse function and neuronal remodeling were evident, including neurofilament medium and heat shock protein 73 (Hsp73) which increased at 1 day of abstinence, but returned to normal levels following 100 days of abstinence. -1 and synaptosome-associated protein 25 kDa (SNAP-25) were unchanged at 1 day of abstinence, but were significantly decreased after 100 days. These data demonstrate that while some protein changes return to normal levels following enforced cocaine abstinence, a number remain or become altered after long periods, up to 100 days, of cocaine abstinence. Those protein expression changes that do not reset to pre-cocaine exposure levels may contribute to the persistent relapse potential that occurs in response to cocaine abstinence.

UI MeSH Term Description Entries

Related Publications

Melinda E Lull, and Mandi S Erwin, and Drake Morgan, and David C S Roberts, and Kent E Vrana, and Willard M Freeman
February 2010, BMC neuroscience,
Melinda E Lull, and Mandi S Erwin, and Drake Morgan, and David C S Roberts, and Kent E Vrana, and Willard M Freeman
May 1986, Pharmacology, biochemistry, and behavior,
Melinda E Lull, and Mandi S Erwin, and Drake Morgan, and David C S Roberts, and Kent E Vrana, and Willard M Freeman
February 2014, The international journal of neuropsychopharmacology,
Melinda E Lull, and Mandi S Erwin, and Drake Morgan, and David C S Roberts, and Kent E Vrana, and Willard M Freeman
January 1984, NIDA research monograph,
Melinda E Lull, and Mandi S Erwin, and Drake Morgan, and David C S Roberts, and Kent E Vrana, and Willard M Freeman
September 2012, NeuroImage,
Melinda E Lull, and Mandi S Erwin, and Drake Morgan, and David C S Roberts, and Kent E Vrana, and Willard M Freeman
February 2024, bioRxiv : the preprint server for biology,
Melinda E Lull, and Mandi S Erwin, and Drake Morgan, and David C S Roberts, and Kent E Vrana, and Willard M Freeman
May 1997, Synapse (New York, N.Y.),
Melinda E Lull, and Mandi S Erwin, and Drake Morgan, and David C S Roberts, and Kent E Vrana, and Willard M Freeman
May 1993, The Journal of pharmacology and experimental therapeutics,
Melinda E Lull, and Mandi S Erwin, and Drake Morgan, and David C S Roberts, and Kent E Vrana, and Willard M Freeman
October 2014, Neurotoxicity research,
Melinda E Lull, and Mandi S Erwin, and Drake Morgan, and David C S Roberts, and Kent E Vrana, and Willard M Freeman
July 2012, Addiction biology,
Copied contents to your clipboard!